Table 2 BAL characteristics of sarcoid patients and control subjects
From: TL1A/DR3 axis involvement in the inflammatory cytokine network during pulmonary sarcoidosis
| Â | Cell recovery | Alveolar macrophages | Lymphocytes | CD4+ T cells | CD8+ T cells | ||||
|---|---|---|---|---|---|---|---|---|---|
| Â | x 103/ml | x 103/ml | % | x 103/ml | % | x 103/ml | % | x 103/ml | % |
active sarcoidosis (n: 29) | 300 ± 37 | 208 ± 51 | 76 ± 10 | 79 ± 35 | 24 ± 9 | 69 ± 12 | 83 ± 7 | 13 ± 8 | 19 ± 6 |
inactive sarcoidosis (n: 14) | 110 ± 23 | 109 ± 26 | 96 ± 4 | 6 ± 5 | 5 ± 2 | 4 ± 3 | 58 ± 2 | 3 ± 1 | 37 ± 4 |
controls (n: 8) | 115 ± 17 | 111 ± 24 | 94 ± 3 | 5 ± 4 | 6 ± 3 | 4 ± 2 | 58 ± 6 | 3 ± 2 | 39 ± 7 |